Under the BioVersys and GSK collaboration agreement, GSK is evaluating the early bactericidal activity (EBA) of alpibectir-ethionamide (AlpE) in a pulmonary tuberculosis (TB) trial, in combination ...
Tuberculosis is the leading infectious cause of death around the world, outpaced only by COVID-19 during the first three ...
Asian News International on MSN10d
Rifampicin drug used in TB treatment is expected to be commissioned later this yearThe drug Rifampicin, which is used in serious bacterial infections, particularly Tuberculosis, is expected to be commissioned ...
In an exclusive interview with Rashmi Mabiyan Kaur, Dr. Sandeep Nayar, Principal Director and HOD, Chest and Respiratory ...
For 2007, the WHO estimated 511,000 cases of multidrug-resistant (MDR)-TB, representing approximately ... income settings. Second-line DST is more difficult than first-line DST, but promising ...
New Vision on MSN3d
Drug-resistant TB on the rise in UgandaKAMPALA - Uganda’s fight against tuberculosis (TB) is facing a growing challenge due to the increasing burden of multidrug-resistant TB (MDR-TB). ;Dr Emmanuel Tweyongyere, a senior medical officer and ...
"These districts have surpassed 100 per cent screening coverage among vulnerable populations," said Dr A Rajesham, Joint ...
Experts have expressed concerns that disruptions to treatment will allow the bacteria to further mutate to new, untreatable ...
in combination with first-line TB drugs. Development of AlpE is strongly supported by European Union and European Pharmaceutical Industry through UNITE4TB, an Innovative Medicines Initiative (IMI2) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback